Cargando…
Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward
The biggest-ever outbreak of monkeypox disease in non-endemic countries started in May, 2022. Though no monkeypox case has been reported from India, till mid-June, 2022, yet, considering the rate of spread to the non-endemic countries, there is an urgent need of better understanding of the monkeypox...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419123/ https://www.ncbi.nlm.nih.gov/pubmed/35762024 http://dx.doi.org/10.1007/s13312-022-2578-2 |
_version_ | 1784777106882822144 |
---|---|
author | Lahariya, Chandrakant Thakur, Archana Dudeja, Nonita |
author_facet | Lahariya, Chandrakant Thakur, Archana Dudeja, Nonita |
author_sort | Lahariya, Chandrakant |
collection | PubMed |
description | The biggest-ever outbreak of monkeypox disease in non-endemic countries started in May, 2022. Though no monkeypox case has been reported from India, till mid-June, 2022, yet, considering the rate of spread to the non-endemic countries, there is an urgent need of better understanding of the monkeypox virus and disease epidemiology to help clinicians, public health specialists, and policymakers to be prepared for any eventuality. This review summarises the monkeypox disease epidemiology, clinical features, therapies, vaccines and outlines the measures for preparedness and response for a possible outbreak. The disease is known to cause severe outcome in children, pregnant women, and immunocompromised hosts and this group need to be given special attention. The monkeypox disease outbreak (2022) in non-endemic countries should be used as an opportunity by India and other low and middle income countries to strengthen public health surveillance and health system capacity for outbreak and epidemic preparedness and response. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.1007/s13312-022-2578-2 and is accessible for authorized users. |
format | Online Article Text |
id | pubmed-9419123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-94191232022-08-30 Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward Lahariya, Chandrakant Thakur, Archana Dudeja, Nonita Indian Pediatr Review Article The biggest-ever outbreak of monkeypox disease in non-endemic countries started in May, 2022. Though no monkeypox case has been reported from India, till mid-June, 2022, yet, considering the rate of spread to the non-endemic countries, there is an urgent need of better understanding of the monkeypox virus and disease epidemiology to help clinicians, public health specialists, and policymakers to be prepared for any eventuality. This review summarises the monkeypox disease epidemiology, clinical features, therapies, vaccines and outlines the measures for preparedness and response for a possible outbreak. The disease is known to cause severe outcome in children, pregnant women, and immunocompromised hosts and this group need to be given special attention. The monkeypox disease outbreak (2022) in non-endemic countries should be used as an opportunity by India and other low and middle income countries to strengthen public health surveillance and health system capacity for outbreak and epidemic preparedness and response. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.1007/s13312-022-2578-2 and is accessible for authorized users. Springer India 2022-06-27 2022 /pmc/articles/PMC9419123/ /pubmed/35762024 http://dx.doi.org/10.1007/s13312-022-2578-2 Text en © Indian Academy of Pediatrics 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Lahariya, Chandrakant Thakur, Archana Dudeja, Nonita Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward |
title | Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward |
title_full | Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward |
title_fullStr | Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward |
title_full_unstemmed | Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward |
title_short | Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward |
title_sort | monkeypox disease outbreak (2022): epidemiology, challenges, and the way forward |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419123/ https://www.ncbi.nlm.nih.gov/pubmed/35762024 http://dx.doi.org/10.1007/s13312-022-2578-2 |
work_keys_str_mv | AT lahariyachandrakant monkeypoxdiseaseoutbreak2022epidemiologychallengesandthewayforward AT thakurarchana monkeypoxdiseaseoutbreak2022epidemiologychallengesandthewayforward AT dudejanonita monkeypoxdiseaseoutbreak2022epidemiologychallengesandthewayforward |